CID1231538
Modify Date: 2025-08-26 22:11:36
CID1231538 structure
|
Common Name | CID1231538 | ||
|---|---|---|---|---|
| CAS Number | 354126-20-8 | Molecular Weight | 524.05 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C26H22ClN3O3S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CID1231538CID1231538, a benzothiazole analogue, is a potent GPR35 antagonist (IC50=0.55 μM). GPR35 is a G protein-coupled receptor (GPCR)[1]. |
| Name | N-{2-[(4-Chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(4-morpholinylcarbonyl)benzamide |
|---|---|
| Synonym | More Synonyms |
| Description | CID1231538, a benzothiazole analogue, is a potent GPR35 antagonist (IC50=0.55 μM). GPR35 is a G protein-coupled receptor (GPCR)[1]. |
|---|---|
| Related Catalog | |
| In Vitro | GPR35 has gained special consideration as a result of its association with many diseases including type-2 diabetes, nociceptive pain, inflammation, mild mental retardation syndrome, metabolic disorders, and gastric cancer[1]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C26H22ClN3O3S2 |
| Molecular Weight | 524.05 |
| Exact Mass | 523.079102 |
| LogP | 3.00 |
| Index of Refraction | 1.725 |
| N-{2-[(4-Chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(4-morpholinylcarbonyl)benzamide |
| Benzamide, N-[2-[[(4-chlorophenyl)methyl]thio]-6-benzothiazolyl]-2-(4-morpholinylcarbonyl)- |